192 related articles for article (PubMed ID: 11536173)
21. Molecular dissection of the signaling and costimulatory functions of CD150 (SLAM): CD150/SAP binding and CD150-mediated costimulation.
Howie D; Simarro M; Sayos J; Guirado M; Sancho J; Terhorst C
Blood; 2002 Feb; 99(3):957-65. PubMed ID: 11806999
[TBL] [Abstract][Full Text] [Related]
22. Analysis of immune activation and clinical events in acute infectious mononucleosis.
Williams H; Macsween K; McAulay K; Higgins C; Harrison N; Swerdlow A; Britton K; Crawford D
J Infect Dis; 2004 Jul; 190(1):63-71. PubMed ID: 15195244
[TBL] [Abstract][Full Text] [Related]
23. Activation of NK cell-mediated cytotoxicity by a SAP-independent receptor of the CD2 family.
Bouchon A; Cella M; Grierson HL; Cohen JI; Colonna M
J Immunol; 2001 Nov; 167(10):5517-21. PubMed ID: 11698418
[TBL] [Abstract][Full Text] [Related]
24. The X-linked lymphoproliferative disease gene product SAP is expressed in activated T and NK cells.
Nagy N; Mattsson K; Maeda A; Liu A; Székely L; Klein E
Immunol Lett; 2002 Jun; 82(1-2):141-7. PubMed ID: 12008045
[TBL] [Abstract][Full Text] [Related]
25. Signaling lymphocytic activation molecule expression and regulation in human intracellular infection correlate with Th1 cytokine patterns.
García VE; Quiroga MF; Ochoa MT; Ochoa L; Pasquinelli V; Fainboim L; Olivares LM; Valdez R; Sordelli DO; Aversa G; Modlin RL; Sieling PA
J Immunol; 2001 Nov; 167(10):5719-24. PubMed ID: 11698444
[TBL] [Abstract][Full Text] [Related]
26. The role of SAP in murine CD150 (SLAM)-mediated T-cell proliferation and interferon gamma production.
Howie D; Okamoto S; Rietdijk S; Clarke K; Wang N; Gullo C; Bruggeman JP; Manning S; Coyle AJ; Greenfield E; Kuchroo V; Terhorst C
Blood; 2002 Oct; 100(8):2899-907. PubMed ID: 12351401
[TBL] [Abstract][Full Text] [Related]
27. Disease-causing SAP mutants are defective in ligand binding and protein folding.
Li C; Iosef C; Jia CY; Gkourasas T; Han VK; Shun-Cheng Li S
Biochemistry; 2003 Dec; 42(50):14885-92. PubMed ID: 14674764
[TBL] [Abstract][Full Text] [Related]
28. Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product.
Latour S; Gish G; Helgason CD; Humphries RK; Pawson T; Veillette A
Nat Immunol; 2001 Aug; 2(8):681-90. PubMed ID: 11477403
[TBL] [Abstract][Full Text] [Related]
29. Molecular and immunological basis of X-linked lymphoproliferative disease.
Latour S; Veillette A
Immunol Rev; 2003 Apr; 192():212-24. PubMed ID: 12670406
[TBL] [Abstract][Full Text] [Related]
30. SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells.
Dupré L; Andolfi G; Tangye SG; Clementi R; Locatelli F; Aricò M; Aiuti A; Roncarolo MG
Blood; 2005 Jun; 105(11):4383-9. PubMed ID: 15677558
[TBL] [Abstract][Full Text] [Related]
31. Dual functional roles for the X-linked lymphoproliferative syndrome gene product SAP/SH2D1A in signaling through the signaling lymphocyte activation molecule (SLAM) family of immune receptors.
Li C; Iosef C; Jia CY; Han VK; Li SS
J Biol Chem; 2003 Feb; 278(6):3852-9. PubMed ID: 12458214
[TBL] [Abstract][Full Text] [Related]
32. SAP regulates T(H)2 differentiation and PKC-theta-mediated activation of NF-kappaB1.
Cannons JL; Yu LJ; Hill B; Mijares LA; Dombroski D; Nichols KE; Antonellis A; Koretzky GA; Gardner K; Schwartzberg PL
Immunity; 2004 Nov; 21(5):693-706. PubMed ID: 15539155
[TBL] [Abstract][Full Text] [Related]
33. The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease.
Engel P; Eck MJ; Terhorst C
Nat Rev Immunol; 2003 Oct; 3(10):813-21. PubMed ID: 14523387
[TBL] [Abstract][Full Text] [Related]
34. The SLAM family of immune-cell receptors.
Veillette A; Latour S
Curr Opin Immunol; 2003 Jun; 15(3):277-85. PubMed ID: 12787752
[TBL] [Abstract][Full Text] [Related]
35. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM.
Sayos J; Wu C; Morra M; Wang N; Zhang X; Allen D; van Schaik S; Notarangelo L; Geha R; Roncarolo MG; Oettgen H; De Vries JE; Aversa G; Terhorst C
Nature; 1998 Oct; 395(6701):462-9. PubMed ID: 9774102
[TBL] [Abstract][Full Text] [Related]
36. SLAM-associated protein deficiency causes imbalanced early signal transduction and blocks downstream activation in T cells from X-linked lymphoproliferative disease patients.
Sanzone S; Zeyda M; Saemann MD; Soncini M; Holter W; Fritsch G; Knapp W; Candotti F; Stulnig TM; Parolini O
J Biol Chem; 2003 Aug; 278(32):29593-9. PubMed ID: 12766168
[TBL] [Abstract][Full Text] [Related]
37. Defective NK cell activation in X-linked lymphoproliferative disease.
Benoit L; Wang X; Pabst HF; Dutz J; Tan R
J Immunol; 2000 Oct; 165(7):3549-53. PubMed ID: 11034354
[TBL] [Abstract][Full Text] [Related]
38. Signaling lymphocytic activation molecule is expressed on CD40 ligand-activated dendritic cells and directly augments production of inflammatory cytokines.
Bleharski JR; Niazi KR; Sieling PA; Cheng G; Modlin RL
J Immunol; 2001 Sep; 167(6):3174-81. PubMed ID: 11544303
[TBL] [Abstract][Full Text] [Related]
39. Pathogenesis and diagnosis of X-linked lymphoproliferative disease.
Gilmour KC; Gaspar HB
Expert Rev Mol Diagn; 2003 Sep; 3(5):549-61. PubMed ID: 14510176
[TBL] [Abstract][Full Text] [Related]
40. Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targets.
Hislop AD; Palendira U; Leese AM; Arkwright PD; Rohrlich PS; Tangye SG; Gaspar HB; Lankester AC; Moretta A; Rickinson AB
Blood; 2010 Oct; 116(17):3249-57. PubMed ID: 20644117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]